Gender Differences in Utilization of Specialized Heart Failure Clinics

Lusine Abrahamyan1,2, Yeva Sahakyan2, Harindra C Wijeysundera2,3,4,5

  • 11 Institute of Health Policy, Management and Evaluation (IHPME), University of Toronto , Toronto, Canada .

Insights

Men and women with heart failure (HF) show different characteristics but receive similar care in specialized clinics. Further research is needed to understand why fewer women enroll in these HF programs.

Area of Science:

  • Cardiology
  • Health Services Research

Background:

  • Heart failure (HF) affects men and women equally, yet care disparities persist.
  • Understanding gender-based differences in HF care is crucial for equitable treatment.

Purpose of the Study:

  • To investigate gender disparities in patient profiles, diagnostic testing, medication, and referrals within Ontario's specialized multidisciplinary ambulatory HF clinics.
  • To evaluate the management of heart failure (HF) patients based on gender.

Main Methods:

  • Retrospective chart review of 884 patients from 9 randomly selected HF clinics in Ontario.
  • Data abstraction included demographics, comorbidities, diagnostics, medications, and referrals over one year.
  • Descriptive statistics and regression analysis were used to compare gender differences.

Main Results:

  • Women (35.5%) were older, had better systolic function, worse functional status, and different comorbidity profiles than men.
  • No significant gender differences were found in echocardiographic assessments or evidence-based medication prescription rates.
  • Men were more likely to be referred for electrophysiology studies; cardiac rehabilitation and dietary counseling referrals were low for both genders.

Conclusions:

  • Specialized HF clinics enroll more men than women.
  • Despite clinical differences, patient management appears similar between genders in these clinics.
  • The low enrollment of women in ambulatory HF clinics requires further investigation.
Abstract

Related Concept Videos

Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
648
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
966
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
402
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.0K